Results 71 to 80 of about 982 (100)

177Lu-DOTA-TATE in Peptide Receptor Radionuclide Therapy: first year experience in Turkey

2011
[No abstract available]
Kabasakal, L., Demirci, E., Ocak, M., Decristoforo, C., Papilla, C., Araman, A., Uslu, I.   +6 more
openaire   +1 more source

Preparation of therapeutic dose of 177Lu-DOTA-TATE using a novel single vial freeze-dried kit: a comparison with 'in-situ' preparation at hospital radiopharmacy.

Current radiopharmaceuticals, 2015
Patient dose of (177)Lu-DOTA-TATE, used for providing radiotherapeutic treatment to the patients suffering from cancers of neuroendocrine origin, could be prepared at the hospital radiopharmacy either 'in-situ' or by using freezedried kits. The objective of the present work is to formulate and evaluate a single vial freeze-dried DOTA-TATE kit, which is
Tapas, Das, Sharmila, Banerjee, Ajit, Shinto, K K, Kamaleshwaran, H D, Sarma   +4 more
openaire   +1 more source

Super-selective hepatic arterial infusions as established technique ('ARETAIEION' Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013
Aim of this study was to evaluate the effectiveness of non-carrier added (n. c. a.) [177Lu]DOTA-TATE in inoperable liver metastases, positive for sst2 receptor overexpression (verified by Octreoscan and confirmed by biopsy) due to neuroendocrine gastroenteropancreatic (GEP) tumors.
G S, Limouris, I, Karfis, A, Chatzioannou, M I, Paphiti, M, Lyra, K, Gennatas, G, Nikou, D, Voros, G P, Pragulidis, A A, Polydorou, A, Gouliamos   +10 more
openaire   +1 more source

177Lu-DOTA-TATE therapy in patients with NETs: Response to treatment and long-term survival update

2016
[No abstract available]
Demirci, E., Sahin, O. Erdem, Ocak, M., Aygun, A., Uslu, I., Kabasakal, L.   +5 more
openaire   +1 more source

Relationship of tumor absorbed doses of 177Lu-DOTA-TATE treatment and uptake in pre-therapeutic Ga68 DOTA-TATE PET/CT imaging

2013
[No abstract available]
Demirci, E., Kabasakal, L., Yeyin, N., Ocak, M., Toklu, T., Selcuk, N., Kanmaz, B.   +6 more
openaire   +1 more source

Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms

European Journal of Nuclear Medicine and Molecular Imaging, 2021
Darpan N Pandya, Zhen Wang, Robert W Engelman   +2 more
exaly  

P100 - ANÁLISIS DE SUPERVIVENCIA, TOXICIDAD Y FACTORES PRONÓSTICOS EN PACIENTES CON TUMORES NEUROENDOCRINOS METASTÁSICOS TRATADOS CON 177LU-DOTA-TATE

Revista Española de Medicina Nuclear e Imagen Molecular, 2023
Angela Leiva Montejo, Inmaculada Ros Madrid, Ana Sofía de Agrela Serrao, Denisse Rocio Cáceres Silva, Claudia Ruiz Corbalán, Laroussi Mohamed Salem, Jose Luis Navarro Fernández, José Fulgencio Contreras Gutiérrez, María Isabel Castellón Sánchez   +8 more
openaire   +1 more source

Head-to-Head Comparison of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in Patients With Tumor-Induced Osteomalacia: A Prospective Study

Frontiers in Oncology, 2022
Peipei Wang, Weibo Xia, Xiaoping Xing
exaly  

The development and validation of a high performance liquid chromatography method to determine the radiochemical purity of [177Lu]Lu-HA-DOTA-TATE in pharmaceutical preparations

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2021
L Van Andel, Jos H Beijnen, Else A Aalbersberg   +2 more
exaly  

Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC

European Journal of Nuclear Medicine and Molecular Imaging, 2021
Heribert Hänscheid, Philipp E Hartrampf, Andreas Schirbel   +2 more
exaly